• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Agape ATP Corporation filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8/28/24 9:01:00 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care
    Get the next $ATPC alert in real time by email
    false --12-31 0001713210 0001713210 2024-08-28 2024-08-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(D)

    OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): August 28, 2024 (August 15, 2024)

     

    AGAPE ATP CORPORATION

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-41835   36-4838886
    (State or other jurisdiction   (Commission   (IRS Employer
    of incorporation)   File Number)   Identification No.)

     

    1705 – 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia,

    Taman Desa, Kuala Lumpur, Malaysia 58100

    (Address of principal executive offices) (Zip Code)

     

    +(60) 192230099

    (Registrant’s telephone number, including area code)

     

    N/A

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.0001 per share   ATPC   NASDAQ Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging Growth Company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     
     

     

    Item 3.03 Material Modification to Rights of Security Holders.

     

    To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference.

     

    Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.

     

    Agape ATP Corporation (the “Company”) filed on August 15, 2024 a Certificate of Change Pursuant to NRS 78.209 of the Company with the Secretary of State of the State of Nevada (the “Certificate of Change”) to effect a 1-for-20 reverse stock split (the “reverse stock split”) of the shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) on August 30, 2024. The Certificate of Change also decreases the number of authorized shares of Common Stock from 1,000,000,000 to 50,000,000. No fractional shares will be issued in connection with the reverse stock split and fractional shares will be rounded up to the nearest whole number.

     

    The Common Stock will begin trading on a reverse stock split-adjusted basis on the Nasdaq Capital Market when the market opens on August 30, 2024. The trading symbol for the Common Stock will remain “ATPC.” The Common Stock was assigned a new CUSIP number (008389 207) following the reverse stock split.

     

    The Company will adjust the number of shares available for the number of outstanding awards, the exercise price per share of outstanding stock options   and other terms of outstanding awards issued to reflect the effects of the reverse stock split.

     

    The foregoing description of the Certificate of Change does not purport to be complete and is qualified in its entirety by reference to the Certificate of Change, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

     

    Item 7.01 Regulation FD Disclosures.

     

    On August 28, 2024, the Company issued a press release announcing the anticipated completion of the reverse stock split. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

     

    The information contained in this Item 7.01 and the accompanying exhibit is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this Item 7.01 and the accompanying exhibit shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference.

     

    Item 9.01. Financial Statements and Exhibits.

     

    c) Exhibits

     

    3.1 Certificate of Change of Agape ATP Corporation
    99.1 Press Release, dated August 28, 2024
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    2
     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      AGAPE ATP CORPORATION
       
    Date: August 28, 2024 By: /s/ How Kok Choong
      Name: How Kok Choong
      Title: Chief Executive Officer, President, Director, Secretary and Treasurer (Principal Executive Officer)

     

    3

    Get the next $ATPC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ATPC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATPC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ATPC Expands Global Market Footprint to Spearhead Medical Innovation with MoUs in Indonesia

      Agreements to drive clinical research, enhance product safety, and combat respiratory diseases KUALA LUMPUR, MALAYSIA / ACCESSWIRE / November 29, 2024 / NASDAQ-listed AGAPE ATP Corporation ("ATPC"), today announced the signing of three Memorandums of Understanding ("MOUs") with prominent healthcare institutions in Indonesia. This initiative aims to advance medical research, introduce innovative treatment strategies and strengthen training programs to address respiratory diseases such as tuberculosis (TB) and chronic obstructive pulmonary disease (COPD). The signing marks a key milestone in ATPC's strategic expansion plans in Indonesia and Southeast Asia.(L-R): Dr. Fernando Cortizo, ED, Prof.

      11/29/24 9:00:00 AM ET
      $ATPC
      Medical/Nursing Services
      Health Care
    • Agape ATP Corporation - Synergising Innovation Across Business Pillars to Make the World a Better Place

      ATPC Unveils Its Multifaceted Business Pillars to Drive Global Wellness and Sustainability KUALA LUMPUR, MALAYSIA / ACCESSWIRE / October 10, 2024 / NASDAQ-listed AGAPE ATP Corporation ("ATPC"), is proud to present its multifaceted business pillars, each driven by a shared vision to make the world a better place. With a strong commitment to sustainability, health, and enhancing quality of life, ATPC has strategically developed six (6) core pillars that work in synergy to address the world's most pressing challenges, from energy conservation to advanced medical care.ATPC Green Energy ("AGE") spearheads ATPC's efforts in the energy sector, with initiatives aiming to provide sustainable energy s

      10/10/24 9:20:00 AM ET
      $ATPC
      Medical/Nursing Services
      Health Care
    • ATPC and FORMEDIC Technologies Announce Strategic Collaboration to Launch LEGA, a Revolutionary Respiratory Care Device

      Innovative Collaboration Brings Advanced Respiratory Solutions to a Global Market KUALA LUMPUR, MALAYSIA / ACCESSWIRE / September 30, 2024 / NASDAQ-listed AGAPE ATP Corporation ("ATPC"), is proud to announce a strategic collaboration with FORMEDIC Technologies Sdn. Bhd. ("FORMEDIC Technologies") to introduce LEGA, an electronic chest percussion device for respiratory care. This partnership marks a major advancement in respiratory health, as the two companies combine their strengths to address the growing demand for advanced respiratory solutions.LEGA, FORMEDIC's flagship product, assists patients with chronic obstructive pulmonary diseases ("COPD"), pneumonia, bronchiectasis, and other lung-

      9/30/24 11:45:00 PM ET
      $ATPC
      Medical/Nursing Services
      Health Care

    $ATPC
    SEC Filings

    See more
    • SEC Form 10-Q filed by Agape ATP Corporation

      10-Q - Agape ATP Corp (0001713210) (Filer)

      5/15/25 12:45:52 PM ET
      $ATPC
      Medical/Nursing Services
      Health Care
    • SEC Form 424B3 filed by Agape ATP Corporation

      424B3 - Agape ATP Corp (0001713210) (Filer)

      4/22/25 4:05:41 PM ET
      $ATPC
      Medical/Nursing Services
      Health Care
    • SEC Form EFFECT filed by Agape ATP Corporation

      EFFECT - Agape ATP Corp (0001713210) (Filer)

      4/22/25 12:15:18 AM ET
      $ATPC
      Medical/Nursing Services
      Health Care

    $ATPC
    Leadership Updates

    Live Leadership Updates

    See more
    • Agape ATP Corporation Announces US$1 Million Share Repurchase Plan

      KUALA LUMPUR, MALAYSIA / ACCESSWIRE / November 22, 2023 / AGAPE ATP Corporation (NASDAQ:ATPC) ("ATPC" or the "Company") announced that its board of directors has authorized a share repurchase plan under which the Company may repurchase up to US$1 million of its shares over the next 6 months. The board of directors have also approved the appointment of Network 1 Financial Securities as the broker to execute the repurchase on behalf of ATPC.The share repurchases may be made from time to time in the open market transactions, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance with applicable secur

      11/22/23 9:00:00 AM ET
      $ATPC
      Medical/Nursing Services
      Health Care